Boomer Olsen

Absolutely delighted to see our FreeDM2 randomised controlled trial published in The Lancet Diabetes & Endocrinology. A landmark UK study of the use of CGM in people living with T2DM #dukpc26 @LalanthaL @drpratikc @MEvansCambridge @TomCrabtree90 @DrAliLumb thelancet.com/journals/landi…

A multimodal AI agentic model that integrates electronic medical records, lifestyle, layers of biologic omics data to predict health outcomes and, with perturbations, "what if" scenarios a person improved lifestyle or took a medication @Cell_Metabolism sciencedirect.com/science/articl…

The multitude of ways that jack up American healthcare costs (without improving outcomes) @armollica @WSJGraphics @annawmathews gift link wsj.com/health/healthc…

Genomics of GLP-1 drug response and side effects With genomic and demographic data it's possible to predict magnitude of weight loss response @23andMe nature.com/articles/s4158…

New 3i Investigator Article Alert!! Quantifying lifetime risk for 1,401 infectious diseases across the diabetes spectrum using a Bayesian approach pubmed.ncbi.nlm.nih.gov/41654821/?utm_…

#T1D and the #Olympic #Games. Absolutely!! See: Managing a Competitive #Athlete Newly Diagnosed With Type 1 #Diabetes - goo.gl/scholar/BUL4xJ #ScholarAlerts

Bayesian statistics for clinical research This review provides a brief account of the philosophical and methodological differences between Bayesian and frequentist approaches and survey the use of Bayesian methods for the design and analysis of clinical research. #Bayesian #bayestheorem #ClinicalTrial #Probabilities thelancet.com/journals/lance…

Medical AI doesn’t just need to be accurate. It needs to be explainable. A new framework, xHAIM, uses generative AI to turn multimodal patient data into interpretable summaries + predictions, boosting performance AUC from ~80% → 91%. nature.com/articles/s4174…

In the post-AlphaFold era, drug discovery is on a tear —Genome-wide virtual screening @ScienceMagazine science.org/doi/10.1126/sc… —Transforming the industry in many ways @TheEconomist economist.com/leaders/2026/0…

7,000 #steps a day is generally associated with a reduced risk of #T2D, but those at high genetic risk need more steps (~7,800) to reduce their risk! doi.org/10.1210/clinem…

Continuous glucose monitoring (CGM) enables real-time assessment of glucose trends in individuals with type 2 #diabetes, complementing or replacing fingerstick and HbA1c monitoring. 💡 This JAMA Insights discusses CGM use for type 2 diabetes. ja.ma/4sfck0J

#UVA #AID team. Safety and Feasibility of a Fully Automated Insulin Delivery System: FCL@ Home, a Multicenter... - goo.gl/scholar/EvUPQP #ScholarAlerts

An open-source screening platform accelerates discovery of drug combinations nature.com/articles/s4146…

Causes and clinical consequences of low concordance between #CGM sensor-detected and person-reported #hypo ... - goo.gl/scholar/rw66An #ScholarAlerts

Natural daylight and improved glucose control in Type 2 diabetes cell.com/cell-metabolis… @Cell_Metabolism

Editor's Note: Defining obesity by clinical outcomes, not just body size, may advance care and target those at greatest health risk. ja.ma/4amATT2

Delighted to share our latest now published in@NatureComms, where we found a new role for mitochondrial programming of SC-β cell fate through PPARα! We're excited for the potential to target mitochondria to improve SC-islets to treat #T1D! nature.com/articles/s4146…

Dermal #Glucose Sensing has a Shorter Time Lag Relative to Blood Glucose: Implications for #Hypoglycemia Detection and #TIR journals.sagepub.com/doi/10.1177/19…

Presented at #SVIN25: CREST-2: In high-grade asymptomatic carotid stenosis, addition of stenting to medical therapy led to a lower risk of stroke over a 4-year period. Endarterectomy did not lead to a significant benefit. Full results: nej.md/3LK9kst Editorial: Managing Asymptomatic Carotid Stenosis nej.md/482XjG1 @svinsociety

Multimodal learning enables chat-based exploration of single-cell data go.nature.com/3WPGJnW